Skip to content

AMI Co., Ltd. New service AMI releases “Remote auscultation reading service beta version” that connects doctors

AMI Co., Ltd.
[New service] AMI releases “Remote auscultation interpretation service beta version” that connects doctors
-Free trial available for a limited time-
AMI Co., Ltd. (Head Office: Kagoshima City, Kagoshima Prefecture, Head Office: Minamata City, Kumamoto Prefecture, Representative Director and CEO: Shinpei Ogawa, hereinafter referred to as the “Company”) connects doctors using the “AMI-SSS01 series of phonocardiogram testing devices*1”. “Remote auscultation reading *2 service beta version” will be released on September 25, 2023.
We also plan to offer it as a free trial until March 2024.
・Service details URL:
This is a site exclusively for medical professionals.
This project is being developed with support from the New Energy and Industrial Technology Development Organization (NEDO), a national research and development agency.
[Image 1:×282.png ]
*1 Brand name: Phonocardiogram testing device AMI-SSS01 series Approval number: 30400BZX00218000
*2 “Remote image reading” is the transmission of images (CT and MR images) taken at medical institutions to doctors using a network for image diagnosis.
Our company is working on the early detection of heart disease, which is a global social issue in the medical and welfare field, through “auscultation DX.”
The “auscultation DX” we aim for is not only to digitize auscultation, but also to solve problems in the field by utilizing it in medical settings, clinical research, medical education, and telemedicine. Japan is the first country in the world to become a super-aging society, and it is predicted that a heart failure pandemic*3 will arrive in the near future*4. On the other hand, problems such as regional disparities in medical care and a shortage of doctors are expected to worsen in the future, due to a decline in the labor force, a decline in the quality and quantity of medical services due to depopulation, and an increase in transportation costs.
In order to overcome this situation, we have launched the “AMI-SSS01 series of phonocardiogram examination devices”, a product that solves the problems of accuracy, difficulty, frequency, and distance of heart disease examinations by utilizing “auscultation DX”. We have developed the “Remote Auscultation Interpretation Service Beta Version”.
*3 The significant increase in the number of heart failure patients due to the increase in the elderly population is sometimes referred to as a “heart failure pandemic,” likening it to the explosive spread of infectious disease patients. Japan Heart Foundation.
*4 Shimokawa H, Miura M, Nochioka K, Sakata Y. Heart failure as a general pandemic in Asia. Eur J Heart Fail. 2015 Sep;17(9):884-92. doi: 10.1002/ejhf.319. Epub 2015 Jul 29. Created by AMI Co., Ltd. based on PMID: 26222508.
-Overview of “Remote Auscultation Interpretation Service Beta Version”- “Remote auscultation interpretation service beta version” is a service that allows you to share heart sound data on the cloud and receive remote support from medical professionals who are familiar with auscultation.
By utilizing the “Phonocardiogram Testing Device AMI-SSS01 Series”, our company’s commitment to visualized heart sound data and sound quality that covers the lowest range of human hearing (20 ㎐) will be available on the cloud. However, it can be reproduced and shared with the same quality even by remote doctors. This allows you to discuss the findings of the auscultation and receive assistance in determining whether a detailed examination is necessary.
 Step1: Upload the test data acquired with the “phonocardiogram test device AMI-SSS01 series” to the cloud
Step 2: Return the analysis report with comments on findings from a medical professional who is familiar with auscultation.
[Image 2:×236.png ]
(Since the service is in beta version, the functions and service content provided may change without notice.)
-Telemedicine initiatives-
Since fiscal 2018, our company has been working on a project commissioned by Minamata City, Kumamoto Prefecture, “Preliminary Medical Examination Demonstration Project Utilizing a Remote System – Cloud Kenshin (R),” and from fiscal 2020, we have been working on a project commissioned by Minamata City, Kumamoto Prefecture. We worked on a demonstration project to connect clinics in remote areas online. We also conducted field verification of remote auscultation on a remote island (Shimokoshikijima) in Satsumasendai City, Kagoshima Prefecture.
・Expand the scope of the online medical treatment demonstration project undertaken by Minamata City, National Health Insurance Minamata City General Medical Center and AMI
・Tripartite agreement concluded with Minamata City, Kumamoto Prefecture and National Health Insurance Minamata City General Medical Center
・Close contact! AMI conducts a demonstration of a video chat system that supports remote auscultation on a remote island in Kagoshima Prefecture (Shimokoshikijima)
-Related article-
・[Pharmaceutical approval] AMI’s “Phonocardiogram AMI-SSS01 series” becomes wireless (wireless connection) and receives approval for some changes.
・Obtained regulatory approval for the “AMI-SSS01 series of
phonocardiogram testing devices”
-AMI Co., Ltd.-
Our company is a research and development startup from Kyushu that is working on “auscultation DX*” through the research and development of “Super Stethoscope (a telemedicine compatible stethoscope with heart disease diagnosis assist function)”. By developing products that utilize acoustic engineering, electronic engineering, and AI technology and implementing telemedicine services in society, we aim to create a world where everyone can receive high-quality medical care, no matter where they are.
*We not only digitize auscultation, but also use it in medical settings, clinical research, medical education, telemedicine, etc., thereby providing new value to medical settings.
This is our company’s promotional video. Please take a look. URL:
[Video 2:]
[Table 2: ]

More details about this release:

%d bloggers like this: